Y Biologics Inc (338840) Stock Price & News

338840:KOSDAQ

Y Biologics Inc

₩10,910.00

-8.40%

(-1,000.00) 1D

Jun 26, 3:30:30 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 338840...

Open

₩11,810

High

₩11,930

Low

₩10,700

Mkt. cap

167.65B

Avg. vol.

121.08K

Volume

145.48K

52-wk high

₩38,000

52-wk low

₩8,880

EPS

-₩2,965

Shares outstanding

15.37M

No. of employees

Open

₩11,810

High

₩11,930

Low

₩10,700

Mkt. cap

167.65B

Avg. vol.

121.08K

Volume

145.48K

52-wk high

₩38,000

52-wk low

₩8,880

EPS

-₩2,965

Shares outstanding

15.37M

No. of employees

Related stocks

LigaChem Biosciences Inc

₩142,900.00

-8.28%

News stories

From sources across the web

Stock Traders Daily

4 hours ago

Avoiding Lag: Real-Time Signals in (RVNU) Movement

Foreign Policy Journal

1 hour ago

AI Spending Surge Poses Little Threat To S&P 500 Buybacks, Deutsche Bank Says (NASDAQ: AMZN, MSFT, GOOGL, META, NYSE: ORCL)

Business Insider

13 hours ago

BofA warns the S&P 500 is flashing technical signals that a 'three-wave' stock correction is underway

CNBC

1 day ago

SpaceX to join the Nasdaq-100 in a fast-tracked process that will drive huge ETF buying demand

About Y Biologics Inc

CEO-

Employees56

Founded2007

Headquarters-

SectorBiotechnology

Websiteybiologics.com

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	1.16B	892.40M	448.64M	281.89M
Cost of goods sold	124.78M	143.76M	102.10M	181.46M
Cost of revenue	124.78M	143.76M	102.10M	181.46M
Research and development expenses	-	-	2.08B	2.73B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.54B	3.28B	624.85M	1.02B
Operating expense	2.54B	3.28B	3.33B	3.98B
Total operating expenses	2.66B	3.42B	3.43B	4.16B
Operating income	-1.50B	-2.53B	-2.99B	-3.88B
Other non operating income	-840.07M	-163.95M	-31.50B	17.56M
EBT including unusual items	-2.34B	-2.69B	-35.11B	-4.32B
EBT excluding unusual items	-2.34B	-2.69B	-35.08B	-4.32B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	25.91M	28.69M
Net income	-2.34B	-2.69B	-35.11B	-4.32B
Net profit margin	-200.51%	-301.87%	-7,826.85%	-1,531.59%
Earnings per share	-	-	-	-
Interest and investment income	-	-	287.25M	248.03M
Interest expense	-	-	-884.15M	-855.57M
Net interest expenses	-	-	-596.90M	-607.54M
Depreciation and amortization charges	-	-	541.62M	156.84M
EBITDA	-1.01B	-2.07B	-2.48B	-3.35B
Gain or loss from assets sale	15.62M	-	16.93M	-

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research